Somatosensory Profiles through quantitative sensory testing of patients with rheumatological diseases

• Conditions: M06; M45; M34; M07; Other rheumatoid arthritis; Ankylosing spondylitis; Systemic sclerosis; Psoriatic and enteropathic arthropathies

• Registration Number: DRKS00030326
• Lead Sponsor: niversitätsklinikum Bonn

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-22
• Study Completion: 2023-01-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Person in the age range of 18-65 years
Confirmed diagnosis of the following underlying rheumatological disease:
- Rheumatoid arthritis according to the 2010 Amercian College of Rheumatology (ACR) criteria.
- Systemic sclerosis according to the 2013 ACR/EULAR classification criteria.
- Ankylosing spondylitis according to the ASAS criteria
- Psoriatic arthritis according to the 2010 American College of Rheumatology (ACR) criteria.
Prior informed consent and informed written consent.

Exclusion Criteria

Inability to give informed and written consent.
Contraindications to the use of QST:
- Skin and soft tissue diseases.
- Pregnancy
- Nursing Period

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Detection of deviations in the pain profile/somatosensory profile by means of a one-time testing using quantitative sensory testing (QST) in patients with rheumatoid arthritis (rheumatoid arthritis, psoriatic arthritis, systemic sclerosis, spondylarthritis).

Secondary Outcome Measures

Name	Time	Method
Recording of the relation between individual parameters of the QST and information in the questionnaire on disease activity, medication, laboratory parameters and organ manifestation.